PDE4DIP

phosphodiesterase 4D interacting protein

Basic information

Region (hg38): 1:148808140-149048286

Previous symbols: [ "CMYA2" ]

Links

ENSG00000178104NCBI:9659OMIM:608117HGNC:15580Uniprot:Q5VU43AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PDE4DIP gene.

  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDE4DIP gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
14
clinvar
14
missense
1
clinvar
2
clinvar
1
clinvar
1
clinvar
3
clinvar
8
nonsense
2
clinvar
2
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 1 2 1 15 6

Highest pathogenic variant AF is 0.00000657

Variants in PDE4DIP

This is a list of pathogenic ClinVar variants found in the PDE4DIP region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-148931908-C-G Hepatocellular carcinoma Pathogenic (Jun 15, 2021)1713062
1-148953028-T-A Benign (Sep 12, 2018)767696
1-148953102-A-C not provided (-)3064028
1-148953147-G-A See cases Pathogenic (Jun 01, 2021)1174534
1-148953206-G-A Likely benign (Feb 01, 2023)2639079
1-148953402-A-G Benign (May 04, 2018)767695
1-148953512-T-G Likely benign (Apr 01, 2023)2639078
1-148953659-C-T Likely benign (Apr 01, 2023)2639077
1-148960636-TTTGCCGTTTCTTCC-T Benign (Sep 12, 2018)767694
1-148960744-GA-G not specified Benign (Mar 28, 2016)403294
1-148961952-G-A Benign (Sep 12, 2018)769243
1-148962237-A-C Likely benign (Mar 01, 2023)2639076
1-148962551-C-T Likely benign (May 04, 2018)769527
1-148962565-A-G Likely benign (Apr 01, 2023)2639075
1-148962598-C-T Likely benign (Nov 01, 2022)2639074
1-148962619-G-A Likely benign (Mar 01, 2023)2639073
1-148967799-G-A Benign (Jan 17, 2024)2791670
1-148968850-AC-A Hepatocellular carcinoma Pathogenic (Jun 15, 2021)1712965
1-148968883-G-A Likely benign (Nov 01, 2022)2639072
1-148968914-C-T Hepatocellular carcinoma Pathogenic (Jun 15, 2021)1712950
1-148991964-T-C Likely benign (Mar 01, 2023)2639071
1-149002894-G-A Likely benign (Mar 01, 2023)2639070
1-149002952-C-T See cases Likely pathogenic (Jun 01, 2021)1174535
1-149003009-G-A Likely benign (Feb 01, 2024)3024762
1-149005085-C-T Hepatocellular carcinoma Pathogenic (Jun 15, 2021)1713030

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PDE4DIPprotein_codingprotein_codingENST00000369356 44240030
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.61e-370.907121928038201257480.0153
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.4011361.01e+31.120.000052514285
Missense in Polyphen365366.660.995475461
Synonymous0.2663763830.9830.00001864083
Loss of Function3.13761120.6800.000006031376

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.009650.00965
Ashkenazi Jewish0.01010.0102
East Asian0.001520.00152
Finnish0.04710.0478
European (Non-Finnish)0.01640.0164
Middle Eastern0.001520.00152
South Asian0.01670.0166
Other0.01030.0103

dbNSFP

Source: dbNSFP

Function
FUNCTION: Functions as an anchor sequestering components of the cAMP-dependent pathway to Golgi and/or centrosomes (By similarity). {ECO:0000250|UniProtKB:Q9WUJ3}.;
Disease
DISEASE: Note=A chromosomal aberration involving PDE4DIP may be the cause of a myeloproliferative disorder (MBD) associated with eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP- PDGFRB fusion protein. {ECO:0000269|PubMed:12907457}.;

Intolerance Scores

loftool
0.984
rvis_EVS
7.99
rvis_percentile_EVS
99.95

Haploinsufficiency Scores

pHI
hipred
hipred_score
ghis
0.547

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
1.00

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Pde4dip
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
cellular protein-containing complex assembly;regulation of Golgi organization
Cellular component
nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril
Molecular function
protein binding;enzyme binding;protein-containing complex scaffold activity